drugset / Trial / NCT00671710
Study of Aminolevulinic Acid to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain
NaSingle-groupOpen-labelDiagnostic
Summary
Tumors of the central nervous system are potentially curable. For tumors of comparable histology and grade, resectability is the most important prognostic factor affecting survival particularly in children. However, the infiltrative nature of the malignant cells produces indistinct borders between normal and malignant tissues, and the lack of easily identifiable tumor margins confounds attempts toward total resection. The investigators propose to identify the borders of tumors intraoperatively using protoporphyrin fluorescence of the malignant cells and thereby provide more complete tumor resection.
Timeline
- Start
- 2008-04
- Primary completion
- 2010-11
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aminolevulinic Acid | Diagnostic / imaging agent | 10 mg/kg | Oral |
| Subject | Aminolevulinic Acid | Diagnostic / imaging agent | 20 mg/kg | Oral |
| Subject | Aminolevulinic Acid | Diagnostic / imaging agent | 30 mg/kg | Oral |